Education
About Us
Working with TipRanks
Follow Us
Nascent Pharma Holdings (NASC)
OTHER OTC:NASC
NASC Stock Chart & Stats
$0.02
--
Market closed
$0.02
--
Day’s Range― - ―
52-Week Range$0.01 - $0.18
Previous CloseN/A
VolumeN/A
Average Volume (3M)35.25K
Market Cap
$1.25M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.42
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding75,841,990
10 Day Avg. Volume42,355
30 Day Avg. Volume35,253
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NASC FAQ
What was Nascent Pharma Holdings’s price range in the past 12 months?
Nascent Pharma Holdings lowest stock price was $0.01 and its highest was $0.18 in the past 12 months.
What is Nascent Pharma Holdings’s market cap?
Nascent Pharma Holdings’s market cap is $1.25M.
When is Nascent Pharma Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nascent Pharma Holdings’s earnings last quarter?
Currently, no data Available
Is Nascent Pharma Holdings overvalued?
According to Wall Street analysts Nascent Pharma Holdings’s price is currently Overvalued.
Does Nascent Pharma Holdings pay dividends?
Nascent Pharma Holdings does not currently pay dividends.
What is Nascent Pharma Holdings’s EPS estimate?
Nascent Pharma Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nascent Pharma Holdings have?
Nascent Pharma Holdings has 75,841,990 shares outstanding.
What happened to Nascent Pharma Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nascent Pharma Holdings?
Currently, no hedge funds are holding shares in NASC
Company Description
Nascent Pharma Holdings
Can B Corp. develops, manufactures, and sells cannabidiol (CBD) based products in the United States. The company provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and life style products through its Website and vending machines, and other medical professionals. It offers its products under the Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil brands. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in February 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.
Technical Analysis
China Pharma Holdings
―
RedHill Biopharma
―
PainReform
―
Universe Pharmaceuticals
―
Shuttle Pharmaceuticals Holdings, Inc.
―